Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II (TUMOSTEO II)
Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II: Texture Analysis and Artificial Intelligence
Sponsor: Central Hospital, Nancy, France
This observational or N/A phase trial investigates Bone Neoplasm and Soft Tissue Neoplasm and is currently actively recruiting participants. Central Hospital, Nancy, France leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Oct 2021 — Jul 2024 [monthly]
Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Aug 2020 — Jan 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Jun 2020 — Aug 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Central Hospital, Nancy, France
- Diagnostic and Interventional Adaptative Imaging Laboratory - IADI
- Emille Gallé Surgical Center - CCEG
- Lorraine Cancer Institute - ICL
For direct contact, visit the study record on ClinicalTrials.gov .